(Q38325289)

2 September 2017

title

Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice (English)

1 reference

2 September 2017

6

Louis M Havekes

1 reference

2 September 2017

Aldo Grefhorst

1

1 reference

2 September 2017

Theo H van Dijk

2

1 reference

2 September 2017

Anke Hammer

3

1 reference

2 September 2017

Fjodor H van der Sluijs

4

1 reference

2 September 2017

Rick Havinga

5

1 reference

2 September 2017

Johannes A Romijn

7

1 reference

2 September 2017

Pieter H Groot

8

1 reference

2 September 2017

Dirk-Jan Reijngoud

9

1 reference

2 September 2017

Folkert Kuipers

10

1 reference

2 September 2017

publication date

7 June 2005

1 reference

American Journal of Physiology - Endocrinology and Metabolism

2 September 2017

published in

1 reference

2 September 2017

volume

289

1 reference

2 September 2017

issue

5

1 reference

2 September 2017

page(s)

E829-38

1 reference

Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Enhanced glucose cycling and suppressed de novo synthesis of glucose-6-phosphate result in a net unchanged hepatic glucose output in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

2000 George Lyman Duff Memorial Lecture: atherosclerosis is a liver disease of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

LXR alpha is the dominant regulator of CYP7A1 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

On the role of liver X receptors in lipid accumulation in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

SREBP-1c mediates the insulin-dependent hepatic glucokinase expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Mass isotopomer analysis: Theoretical and practical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Gene-altered mice and metabolic flux control

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Role of stearoyl-coenzyme A desaturase in lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Rapid transformation of white adipocytes into fat-oxidizing machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Role of LXRs in control of lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Novel roles of liver X receptors exposed by gene expression profiling in liver and adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

OR-1, a member of the nuclear receptor superfamily that interacts with the 9-cis-retinoic acid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Quantification of hepatic carbohydrate metabolism in conscious mice using serial blood and urine spots

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Acute inhibition of hepatic glucose-6-phosphatase does not affect gluconeogenesis but directs gluconeogenic flux toward glycogen in fasted rats. A pharmacological study with the chlorogenic acid derivative S4048.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

LXR, a nuclear receptor that defines a distinct retinoid response pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00165.2005

10.1152/AJPENDO.00165.2005

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference